Oppenheimer initiates Knife River stock coverage with Outperform rating

Oppenheimer initiated Knife River Corp. with an Outperform rating and a $95 price target, implying about 21% upside from the $78.30 share price. The firm cited public infrastructure funding, profitability initiatives, and geographic diversification as key supports, though Oregon funding challenges remain a headwind. Recent Q1 2026 results were mixed, with EPS of -1.4 missing estimates by 64.7% even as revenue rose 16% year over year, alongside a $400 million increase in term B loans and a 25 bps reduction in interest margin.

Analysis

KNF reads as a classic “good business, bad headline” setup: the market is still anchoring on messy near-term earnings and leverage optics while underappreciating how much of the downside is already financed by visible infrastructure demand. The bigger second-order winner is not just KNF’s own margin profile but the scarcity value of domestically sourced aggregates and contracting capacity in a politically favored spending cycle; that tends to tighten pricing in local markets before it shows up cleanly in reported EBITDA.

The credit amendment matters more than the stock move implies. A lower borrowing cost and added term-loan capacity effectively extends the runway for working-capital seasonality and opportunistic M&A, which is important because regional materials businesses usually re-rate when the market believes management can convert scale into margin expansion rather than just chase volume. The risk is that execution credibility remains fragile: one or two more quarters of EPS noise can keep the multiple capped even if revenue trends stay healthy.

Contrarian view: the consensus may be too focused on valuation on a trailing basis and not enough on forward normalization. If infrastructure funding remains intact and Oregon stops being a worsening drag, the name can re-rate over 6-12 months as investors start capitalizing through-cycle cash flow instead of near-term earnings volatility. The main reversal trigger is a sharp slowdown in public bid activity or evidence that margin improvement is being offset by higher mix/transport costs, which would turn the balance sheet flexibility from a positive into just a buffer.

Key Decisions for Investors

• Go long KNF on weakness into the next 1-2 earnings prints; use a staggered entry below recent trading levels and target a 10-15% upside re-rating over 6-12 months if margin normalization becomes visible.
• Pair trade: long KNF / short a more expensive regional infrastructure beneficiary with less balance-sheet flexibility, to isolate the funding-cycle upside while reducing macro beta.
• Buy near-dated call spreads in KNF if bid activity data remains constructive over the next 30-60 days; structure for a controlled premium outlay given execution noise.
• If KNF fails to stabilize after the next quarterly update, cut quickly — this is a thesis that depends on forward orders and margin recovery, not simply on asset value.